Pharma Archives - Page 10 of 68 - Life Sciences Times

Upendra Mishra’s After the Fall Now Available on Amazon, Marking a Bold New Entry into the Transformational Book Market

June 7, 2025

MeMed Reaches 100,000-Patient Milestone for Rapid Infection Diagnostic Test

June 6, 2025

Casma Therapeutics Advances Novel Parkinson’s Drug Candidate Toward Clinical Trials

June 5, 2025

THIS WEEK'S STORIES

Mediar Therapeutics Begins Phase 2 Trial of MTX-463 for Idiopathic Pulmonary Fibrosis

June 5, 2025

Agenus and Zydus Lifesciences Sign $141 Million Deal to Advance Cancer Immunotherapy and Expand U.S. Biologics Manufacturing

June 3, 2025

Ontario Brain Injury Association Warns of Hidden Dangers in Surviving Opioid Overdoses

June 4, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Pharma

Vertex Highlights Potential of ALYFTREK in Cystic Fibrosis at European Conference

Otsuka’s Sibeprenlimab Shows Strong Results in Phase 3 Trial for IgA Nephropathy

Mediar Therapeutics Begins Phase 2 Trial of MTX-463 for Idiopathic Pulmonary Fibrosis

Acerand Therapeutics Begins First-in-Human Trial of ACE-232 for Advanced Prostate Cancer

Seyltx Reports Promising Preclinical Results for Chronic Cough Drug Ifenprodil Ahead of Phase 2 Trials

Most Read

Upendra Mishra’s After the Fall Now Available on Amazon, Marking a Bold New Entry into the Transformational Book Market

AI-Powered Tool Set to Revolutionize Type 1 Diabetes Diagnosis and Treatment

ZEISS CLARUS 700 Retinal Imaging System Receives Approval in China

Vera Whole Health and Anthem Expand Primary Care Access in Richmond Amid Physician Shortage

EDITOR PICKS

Upendra Mishra’s After the Fall Now Available on Amazon, Marking a Bold New Entry into the Transformational Book Market

MeMed Reaches 100,000-Patient Milestone for Rapid Infection Diagnostic Test

Casma Therapeutics Advances Novel Parkinson’s Drug Candidate Toward Clinical Trials

THIS WEEK'S STORIES

Mediar Therapeutics Begins Phase 2 Trial of MTX-463 for Idiopathic Pulmonary Fibrosis

Agenus and Zydus Lifesciences Sign $141 Million Deal to Advance Cancer Immunotherapy and Expand U.S. Biologics Manufacturing

Ontario Brain Injury Association Warns of Hidden Dangers in Surviving Opioid Overdoses

POPULAR CATEGORY

ABOUT US

FOLLOW US